These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10785837)

  • 1. Imaging of nonmotor symptoms in Parkinson syndromes.
    Paulus W; Trenkwalder C
    Clin Neurosci; 1998; 5(2):115-20. PubMed ID: 10785837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging of depression in Parkinson's disease: a review.
    Chagas MH; Linares IM; Garcia GJ; Hallak JE; Tumas V; Crippa JA
    Int Psychogeriatr; 2013 Dec; 25(12):1953-61. PubMed ID: 23992107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rCBF SPECT in Parkinson's disease patients with mental dysfunction.
    Bissessur S; Tissingh G; Wolters EC; Scheltens P
    J Neural Transm Suppl; 1997; 50():25-30. PubMed ID: 9120420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional imaging in Parkinson's disease.
    Dagher A
    Semin Neurol; 2001; 21(1):23-32. PubMed ID: 11346022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies.
    Wen MC; Chan LL; Tan LC; Tan EK
    Eur J Neurol; 2016 Jun; 23(6):1001-19. PubMed ID: 27141858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional imaging studies of non-motoric manifestations of Parkinson's Disease.
    Stoessl AJ
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S13-6. PubMed ID: 20082973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT.
    Ceballos-Baumann AO
    J Neurol; 2003 Feb; 250 Suppl 1():I15-23. PubMed ID: 12761630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.
    Lenka A; Jhunjhunwala KR; Saini J; Pal PK
    Parkinsonism Relat Disord; 2015 Jul; 21(7):683-91. PubMed ID: 25920541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion and metabolism imaging studies in Parkinson's disease.
    Borghammer P
    Dan Med J; 2012 Jun; 59(6):B4466. PubMed ID: 22677251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPECT imaging in psychiatry: introduction and overview.
    Weinberger DR
    J Clin Psychiatry; 1993 Nov; 54 Suppl():3-5. PubMed ID: 8270596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.
    Zou J; Weng RH; Chen ZY; Wei XB; Wang R; Chen D; Xia Y; Wang Q
    CNS Neurosci Ther; 2016 Mar; 22(3):167-77. PubMed ID: 26776081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric aspects of Parkinson's disease.
    Marsh L
    Psychosomatics; 2000; 41(1):15-23. PubMed ID: 10665264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neural areas of emotions in normal and brain pathology assessed by functional neuroimaging methods].
    Kucharska-Pietura K; Pietura R; Masiak M
    Przegl Lek; 2002; 59(10):832-5. PubMed ID: 12632923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of Parkinson's disease and related syndromes using 123I-IMP-SPECT with the ARG method].
    Kageyama H; Kikuchi S; Tashiro K
    Nihon Rinsho; 1997 Jan; 55(1):238-42. PubMed ID: 9014457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of magnetic resonance imaging (MRI) and single photon emission computing tomography (SPECT) for the differential diagnosis of Parkinson's disease and other neurodegenerative disorders presenting as parkinsonism].
    Kohira I
    Nihon Rinsho; 1997 Jan; 55(1):39-42. PubMed ID: 9014421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPECT and PET imaging in mood disorders.
    George MS; Ketter TA; Post RM
    J Clin Psychiatry; 1993 Nov; 54 Suppl():6-13. PubMed ID: 8270597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions.
    Zgaljardic DJ; Foldi NS; Borod JC
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1287-301. PubMed ID: 15480839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.